Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
- Revenue in DKK (TTM)32.11bn
- Net income in DKK4.72bn
- Incorporated2000
- Employees11.64k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symrise AG | 36.74bn | 1.84bn | 100.45bn | 12.94k | 54.07 | 3.53 | 24.90 | 2.73 | 1.78 | 1.78 | 35.31 | 27.22 | 0.6398 | 2.58 | 4.59 | 385,631.80 | 3.27 | 4.68 | 4.04 | 5.61 | 37.57 | 37.62 | 5.11 | 7.60 | 1.86 | 8.75 | 0.3774 | 45.52 | -1.39 | 6.96 | -47.86 | -4.32 | 7.97 | 5.20 |
| Ems Chemie Holding AG | 15.55bn | 3.80bn | 162.10bn | 2.62k | 42.64 | 9.64 | 38.06 | 10.42 | 20.28 | 20.28 | 82.93 | 89.69 | 0.7666 | -- | 5.67 | 730,194.90 | 18.86 | 22.22 | 21.66 | 26.17 | -- | 45.28 | 24.60 | 22.80 | 3.54 | -- | 0.0149 | 86.50 | -5.85 | 1.58 | 1.24 | 1.44 | -10.09 | -2.92 |
| Novozymes A/S | 32.11bn | 4.72bn | 183.47bn | 11.64k | 43.81 | 2.48 | 19.80 | 5.71 | 10.10 | 10.10 | 68.73 | 178.80 | 0.2602 | 2.37 | 5.62 | 2,758,590.00 | 3.82 | 6.22 | 4.12 | 7.37 | 54.90 | 52.87 | 14.70 | 15.01 | 1.04 | 12.20 | 0.2157 | 55.38 | 8.45 | 17.20 | 90.84 | 9.01 | 30.14 | 4.32 |
| Sika AG | 89.11bn | 8.35bn | 227.07bn | 33.86k | 27.22 | 4.16 | 17.93 | 2.55 | 6.48 | 6.48 | 51.93 | 42.43 | 0.7077 | 3.53 | 4.56 | 329,744.60 | 6.64 | 8.50 | 8.42 | 10.57 | 55.24 | 52.95 | 9.38 | 10.32 | 0.9214 | 11.01 | 0.4703 | 32.89 | -4.78 | 7.29 | -16.18 | 4.83 | 23.31 | 8.16 |
Data as of Oct 14 2026. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
17.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 30 Jun 2026 | 12.74m | 3.07% |
| Vanguard Capital Management LLCas of 02 Sep 2026 | 10.68m | 2.58% |
| Invesco Asset Management Ltd.as of 31 Aug 2026 | 10.38m | 2.50% |
| APG Asset Management NVas of 31 Mar 2026 | 7.07m | 1.71% |
| BlackRock Fund Advisorsas of 03 Sep 2026 | 6.79m | 1.64% |
| Pictet Asset Management SAas of 03 Sep 2026 | 5.77m | 1.39% |
| ELEVA Capital SASas of 30 Jun 2026 | 5.26m | 1.27% |
| BlackRock Investment Management (UK) Ltd.as of 08 Oct 2026 | 4.62m | 1.11% |
| Geode Capital Management LLCas of 08 Oct 2026 | 4.39m | 1.06% |
| Impax Asset Management Ltd.as of 31 Aug 2026 | 4.25m | 1.03% |
More ▼
Data from 30 Jun 2026 - 30 Sep 2026Source: FactSet Research Systems Inc.
